Your fact-checks will appear here
Research on the effectiveness of Ginkgo biloba extract EGb-761 for MCI and Alzheimer’s disease.
A small randomized, double‑blind, placebo‑controlled pilot trial of a triple‑ingredient product called Memo® (royal jelly + Ginkgo biloba + Panax ginseng) reported short‑term MMSE gains in patients wi...
Peer‑reviewed randomized clinical trials exist for Ginkgo biloba, phosphatidylserine (PS), and Bacopa monnieri, with many trials reporting small improvements in memory or specific cognitive tests but ...
Randomized trials and systematic reviews show mixed results: some multi‑ingredient multivitamin-mineral (MVM) trials report modest cognitive benefits in older adults while many single‑ingredient and c...
Clinical trials show only a handful of spices or herb-derived compounds have credible, though limited, evidence for improving cognition in people with dementia: saffron has the strongest randomized-tr...
Randomized, peer‑reviewed trials have tested a range of natural formulas and supplements in people with mild cognitive impairment (MCI) — including Ginkgo biloba, saffron, curcumin, blueberry and othe...
Randomized, double-blind, placebo-controlled trials have reported improvements in working memory or attention for several nutraceuticals—most consistently for Bacopa monnieri, some Ginkgo biloba trial...
Randomized controlled trials and recent systematic reviews report modest, inconsistent benefits from several natural supplements for mild cognitive impairment (MCI)—notably Ginkgo biloba, some omega‑3...
MemoBlast’s label, as represented across official product pages and third‑party reviews, lists a mix of botanicals, amino acids, polyphenols and other extracts — names frequently invoked in cognitive‑...